Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Yield10 Bioscience, Inc. |
Dyadic International, Inc. |
Onconetix, Inc. |
Cardiff Oncology, Inc. |
Trevena, Inc. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
YTEN.Q | DYAI | ONCO | CRDF | TRVN | VCNX | |||
Return On Equity | ||||||||
Latest Twelve Months | 450% | -139% | -234% | -74% | 344% | 577% | ||
Fiscal Year - 1 | -133% | -80% | NA | -47% | -134% | -1405% | ||
Fiscal Year - 2 | -86% | -66% | NA | -31% | -61% | -314% | ||
Fiscal Year - 3 | -375% | -56% | NA | -21% | -44% | 234% | ||
Fiscal Year - 4 | -1606% | -29% | NA | -33% | -69% | 109% | ||
Fiscal Year - 5 | -100% | -21% | NA | -192% | -81% | 183% | ||
Average | -308% | -65% | -234% | -67% | -7% | -103% | ||
Median | -116% | -61% | -234% | -40% | -65% | 146% | ||
Benchmarks | Ticker | |||||||
Yield10 Bioscience, Inc. | OTCPK:YTEN.Q | |||||||
Dyadic International, Inc. | NasdaqCM:DYAI | |||||||
Onconetix, Inc. | NasdaqCM:ONCO | |||||||
Cardiff Oncology, Inc. | NasdaqCM:CRDF | |||||||
Trevena, Inc. | OTCPK:TRVN |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | YTEN.Q | DYAI | ONCO | CRDF | TRVN | VCNX | ||
Latest Fiscal Year | Dec-23 | Dec-24 | Dec-23 | Dec-24 | Dec-23 | Dec-24 | ||
LTM Period | Jun-24 | Dec-24 | Sep-24 | Mar-25 | Sep-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 1 | 3 | 2 | 1 | 1 | 1 | ||
Fiscal Year | 0 | 3 | 0 | 1 | 3 | 1 | ||
Fiscal Year - 1 | 0 | 3 | NA | 0 | (0) | 1 | ||
Fiscal Year - 2 | 1 | 3 | NA | 0 | 1 | 0 | ||
Fiscal Year - 3 | 1 | 2 | NA | 0 | 3 | 1 | ||
Fiscal Year - 4 | 1 | 2 | NA | 0 | 0 | 1 | ||
Fiscal Year - 5 | 1 | 2 | NA | 0 | 6 | 1 | ||
Net Income | ||||||||
Latest Twelve Months | (13) | (6) | (52) | (49) | (34) | (19) | ||
Fiscal Year | (14) | (6) | (37) | (45) | (40) | (19) | ||
Fiscal Year - 1 | (14) | (7) | (14) | (41) | (54) | (20) | ||
Fiscal Year - 2 | (11) | (10) | (4) | (39) | (52) | (20) | ||
Fiscal Year - 3 | (10) | (13) | (2) | (28) | (29) | (22) | ||
Fiscal Year - 4 | (13) | (9) | (1) | (23) | (25) | (29) | ||
Fiscal Year - 5 | (9) | (8) | NA | (17) | (31) | (32) | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 6 | 8 | 28 | 74 | 45 | 4 | ||
Latest Fiscal Quarter | 3 | 10 | 62 | 85 | 19 | 3 | ||
Fiscal Year | 4 | 10 | 88 | 97 | 41 | 3 | ||
Fiscal Year - 1 | 8 | 8 | 26 | 82 | 49 | 4 | ||
Fiscal Year - 2 | 20 | 14 | 3 | 116 | 80 | 8 | ||
Fiscal Year - 3 | 15 | 21 | 5 | 150 | 128 | 10 | ||
Fiscal Year - 4 | 17 | 30 | 6 | 135 | 47 | 12 | ||
Fiscal Year - 5 | 13 | 37 | NA | 13 | 67 | 5 | ||
Fiscal Year - 6 | 17 | 43 | NA | 14 | 73 | 22 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 1 | 6 | 10 | 61 | 4 | (2) | ||
Latest Fiscal Quarter | (6) | 2 | 34 | 71 | (23) | (4) | ||
Fiscal Year | (2) | 2 | (6) | 83 | (8) | (4) | ||
Fiscal Year - 1 | 4 | 6 | 22 | 70 | 16 | (2) | ||
Fiscal Year - 2 | 16 | 11 | 1 | 106 | 65 | 5 | ||
Fiscal Year - 3 | 10 | 18 | 5 | 140 | 104 | 7 | ||
Fiscal Year - 4 | (4) | 28 | 6 | 128 | 30 | (27) | ||
Fiscal Year - 5 | 6 | 36 | NA | 7 | 42 | (26) | ||
Fiscal Year - 6 | 13 | 42 | NA | 10 | 35 | (9) |